WOBURN, Mass., April 4, 2023 /PRNewswire/ — ROMEG Therapeutics, LLC (“Romeg”), an innovative drug development company focused on alternative formulations to better meet clinical and patient needs, today announced the publication of results from its recently completed Phase 2 proof of concept study of RMG-03 in COVID-19 patients. The results from the exploratory study, evaluating the effect …
Author Archives: Naomi Vishnupad
WOBURN, Mass., Feb. 1, 2023 /PRNewswire/ — ROMEG Therapeutics, LLC (“Romeg”), an innovative drug development company focused on alternative formulations to better meet clinical and patient needs, today announced that the United States Patent and Trademark Office has issued U.S. Patent No. 11,564,909 (the ‘909 patent) directed to the methods and composition of ROMEG’s proprietary formulation of …